The FDA has decided to Accept the DILI Work Package into the Biomarker Qualification Program. We are very happy to have DIVI, DINI, DIKI and DILI already accepted by the FDA Biomarker Qualification Program! Take [...]

TransBioLine 3rd Consortium Meeting took place in an online format on 8-9th September 2020. Up to 90 people joined the virtual TransBioLine 3rd consortium meeting, having the representation of all consortium partners. Project progress was [...]

The TransBioLine WP4 (Biomarkers of vascular injury) Letter of Intent was accepted by the FDA on February 2020 and the team is in preparation to discuss the FDA recommendations to [...]

TransBioLine Consortium met in Sitges, Barcelona, on the 30th September and 1st October 2019. Members of the 27 partners of the Consortium met in Sitges to report on progress during the first half year of [...]

From February 28th to March 1st 2019 participants from the 27 partners of the Consortium met during two full days to begin a new adventure. The meeting took place in Basel, Switzerland, in Novartis premises [...]

Innovative Medicines Initiative Launches Translational Safety Biomarker Pipeline Project […]